Application
MBOA1 Antibody (Center) western blot analysis in CHO cell line and mouse liver tissue lysates (15ug/lane).This demonstrates the MBOA1 antibody detected MBOA1 protein (arrow).| Product Name | MBOA1 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | MBOAT1; OACT1; Lysophospholipid acyltransferase 1; 1-acylglycerophosphoserine O-acyltransferase; Lysophosphatidylserine acyltransferase; Membrane-bound O-acyltransferase domain-containing protein 1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | OACT1 |
|---|---|
| Alternative Names | MBOAT1 OACT1 Lysophospholipid acyltransferase 1 1-acylglycerophosphoserine O-acyltransferase Lysophosphatidylserine acyltransferase Membrane-bound O-acyltransferase domain-containing protein 1 |
| Molecular Weight(MW) | 56557 Da |
| Function | Acyltransferase which mediates the conversion of lysophosphatidylserine (1-acyl-2-hydroxy-sn-glycero-3-phospho-L- serine or LPS) into phosphatidylserine (1,2-diacyl-sn-glycero-3- phospho-L-serine or PS) (LPSAT activity). Prefers oleoyl-CoA as the acyl donor. Lysophospholipid acyltransferases (LPLATs) catalyze the reacylation step of the phospholipid remodeling pathway also known as the Lands cycle |
| Tissue Specificity | Expressed in neutrophils. |
| Cellular Localization | Membrane; Multi-pass membrane protein (Potential) |
| Entrez Gene | 154141 |
|---|---|
| Nucleotide Accession | NP_001073949.1 |
Application
MBOA1 Antibody (Center) western blot analysis in CHO cell line and mouse liver tissue lysates (15ug/lane).This demonstrates the MBOA1 antibody detected MBOA1 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
